Immtech Pharmaceuticals Inc (immp)
New York, New York
Company Description
Immtech Pharmaceuticals has a vendetta against infectious diseases. The development-stage pharmaceutical company has focused its efforts on finding treatments for bacterial, viral, and fungal infections, including hepatitis C and hospital-acquired infections. Much of the companys work is in the early stages of research and development; it halted work on its clinical-stage candidate pafuramidine in 2008 because of safety issues. Immtech has licensed some of its other drug technology from academic researchers at the University of North Carolina at Chapel Hill and Georgia State University.
Business Contact Information
- Phone
- 212-791-2911
- Fax
- No data
- Website
- http://www.immtechpharma.com
- No data
- No data
- Address
- 1 N End Ave, New York, New York, 10282, United States
Industry & Classification
- Industry Name Level 1
- No data
- Industry Name Level 2
- No data
- Industry Name Level 3
- No data
NAICS Codes
No data
SIC Codes
No data
Company Details
- Employees
- No data
- Annual Revenue
- No data
- Established
- No data
- Total Funding
- No data
- Latest Funding
- No data
Related Companies
Own this business?
Keep your profile accurate — or ask us to take it down. We acknowledge requests within 7 days and resolve them within 30 days.
Prefer email? privacy@facturmfg.com